Background
==========

In Europe, uveitis is one of the main causes of blindness middle-age, affecting 5--10% of individuals \[[@b1-medscimonit-24-8734]--[@b4-medscimonit-24-8734]\]. Uveitis is a heterogeneous group of inflammatory ocular diseases differing in etiology and anatomical location and includes an inflammatory process that can be caused by a variety of endogenous and exogenous factors \[[@b5-medscimonit-24-8734]--[@b8-medscimonit-24-8734]\]. Uveitis induced by some topically or systemically administered drugs has been also reported \[[@b9-medscimonit-24-8734]--[@b11-medscimonit-24-8734]\]. Some types of malignancy may also present with uveitis, which may delay the detection of the underlying cause \[[@b12-medscimonit-24-8734]--[@b14-medscimonit-24-8734]\].

Due to the variety of causes of uveitis, the diagnosis and treatment require an interdisciplinary approach. There have also been reports of geographical variations in the etiology of uveitis \[[@b5-medscimonit-24-8734],[@b6-medscimonit-24-8734]\]. Therefore, the aims of this study were to review the causes, presentation, and clinicopathological associations of uveitis in a retrospective series of patients referred to the Department of Ophthalmology, Medical University of Warsaw, Poland, and to compare the findings with previously published studies from other European countries, to identify the similarities and differences.

Material and Methods
====================

Patients and study design
-------------------------

The study was conducted according to the guidelines of the Declaration of Helsinki.

All records of patients referred with a presumptive diagnosis of uveitis from the Department of Ophthalmology, the Medical University of Warsaw, between 2005 and 2015 were reviewed. The anatomical classification and diagnosis of uveitis were based on the criteria of the International Uveitis Study Group (IUSG) \[[@b15-medscimonit-24-8734],[@b16-medscimonit-24-8734]\].

Ophthalmic investigations
-------------------------

From the review of the clinical records, standard ophthalmic examination was performed in all cases and when required, ocular ultrasonography, fluorescein or indocyanine green angiography, optical coherence tomography (OTC), perimetry, and magnetic resonance imaging (MRI) of the head were performed.

General clinical and laboratory investigations
----------------------------------------------

All patients had a general medical evaluation, including a chest X-ray, blood pressure measurement, urinalysis, complete blood cell count (CBC) with differential, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) test. Depending on the clinical picture, other tests included genetic tests for the presence of HLA B-27 and HLA A-29, and serological tests for toxoplasmosis, toxocariasis, herpes viruses, borreliosis, bartonellosis, syphilis, and human immunodeficiency virus (HIV) infection. In selected cases, additional investigations were performed, including tests for angiotensin-converting enzyme (ACE), antinuclear antibodies (ANAs), the anti-neutrophil cytoplasmic antibody (ANCA) test, and the QuantiFERON-TB test for infection with *Mycobacterium tuberculosis*. All cases of uveitis from sarcoidosis and tuberculosis were associated with pulmonary disease. Patients with suspected systemic disease were referred to a rheumatologist, pulmonologist, or neurologist and some patients had magnetic resonance imaging (MRI) or lumbar puncture.

Literature review of cases of uveitis in Europe
-----------------------------------------------

Using the Medline database, a review of the literature was performed from 1976--2017 that reported observational data from patients with uveitis in Europe, using the following terms for the literature search: 'uveitis,' 'pattern of uveitis,' 'uveitis in Europe,' and 'epidemiology of uveitis.' Twenty-four articles published in the years 1976--2017, reporting uveitis in 24,126 patients in Europe were identified \[[@b19-medscimonit-24-8734]--[@b43-medscimonit-24-8734]\]. The records of patients referred to the Department of Ophthalmology and the literature data were analyzed in terms of gender, age, and major causes of uveitis, to identify similarities and differences.

Statistical analysis
--------------------

Statistical analysis was performed using STATA/Special Edition version 14.2 (Stata Corp LP, College Station, Texas, USA). The mean ± standard deviation (SD) were used. The frequency of occurrence were expressed as percentages (%). For the contingency tables, the chi-squared (χ^2^) test of independence was performed. Multinomial regression analysis was applied to calculate relative risk ratios (RRR) for a selected anatomical localization of uveitis versus all other localizations and by gender. Probabilities of occurrence of a given condition were estimated using logistic regression models. Gender-related differences in the investigated parameters between the groups were tested using the multifactorial analysis of variance (ANOVA) without replication. Fisher's protected least-significant difference (LSD) test for multiple comparisons was performed to detect statistically significant differences between pairs of results. A p-value of \<0.05 was considered statistically significant.

Results
=======

Retrospective observational study findings (Poland, 2005--2015): Demographic findings for patients with uveitis
---------------------------------------------------------------------------------------------------------------

Following a review of the clinical records of patients with a presumptive diagnosis of uveitis from the Department of Ophthalmology, the Medical University of Warsaw, between 2005 and 2015 identified 282 adult patients (Caucasian), including 174 women (61.7%) and 108 men (38.7%). A total of 279 patients were included in the final analysis, 172 women (61.6%) and 107 men (38.3%). Three patients were excluded for the following reasons. Two sisters were ultimately diagnosed with transthyretin amyloidosis masquerading as posterior uveitis \[[@b44-medscimonit-24-8734]\]. A 42-year-old man was diagnosed with primary intraocular lymphoma, confirmed by vitreous biopsy and flow cytometry.

Of the 279 patients reviewed, anterior uveitis was diagnosed in 26.5% (22.1% women *vs.* 33.6% men), intermediate uveitis in 12.9% (11.1% women *vs.* 15.9% men), posterior uveitis in 48.4% (51.2% women *vs.* 43.9% men), and panuveitis in 12.2% (15.7% women *vs.* 6.5% men). The gender differences were statistically significant (χ^2^=9.769; df=3; p=0.021). Anterior uveitis was found to affect men more frequently than women (RRR=1.79; 95% CI, 1.04--3.06; p=0.035); panuveitis was less prevalent among men (RRR=0.38; 95% CI, 0.16--0.90; p=0.028) ([Table 1](#t1-medscimonit-24-8734){ref-type="table"}).

The mean age of the 279 patients reviewed was 38.3±15.3 years. There were no statistically significant differences in patient age by gender by analysis of variance (ANOVA) (F=1.031; df=1. 274; p=0.261. However, age was significantly associated with differences in diagnosis (F=16.342; df=3. 274; p\<0.001). The highest mean age was for subjects with panuveitis (48.7±13.1 years) and the lowest mean age was found for patients with intermediate uveitis (32.1±11.9 years). Fisher's test of least-significant difference (LSD) for multiple comparisons showed that the mean age differed significantly between patients with anterior uveitis compared with intermediate uveitis (p\<0.001); anterior uveitis compared with posterior uveitis (p\<0.001); intermediate uveitis compared with panuveitis (p\<0.001), and posterior uveitis compared with panuveitis (p\<0.001) ([Table 2](#t2-medscimonit-24-8734){ref-type="table"}). Unilateral presentation of uveitis was found in 60.5% (n=169) and a bilateral presentation of uveitis was present in 39.5% (n=110) of the patients.

Retrospective observational study findings (Poland, 2005--2015): Anatomical and etiological distribution of uveitis
-------------------------------------------------------------------------------------------------------------------

The etiology of uveitis was established in 76.4% (n=213) of all cases in the retrospective study. The main cause of inflammation of the uveal tract was not established in 23.6% (n=66) despite evaluation by other medical specialists and additional investigations. The distribution of the final diagnosis of uveitis, by anatomical classification, is shown in [Table 3](#t3-medscimonit-24-8734){ref-type="table"}.

Fuchs uveitis was the most common cause of anterior uveitis (45.9%); most intermediate uveitis (66.6%) and panuveitis (29.4%) was idiopathic; toxoplasmosis was the most frequent cause of posterior uveitis (35.5%). Posterior uveitis was the most common anatomical diagnosis in 135 patients (48.4%), followed by anterior uveitis in 74 patients (26.5%), intermediate uveitis in 36 patients (12.9%), and panuveitis in 34 patients (12.2%). Overall, the etiology of uveitis was ocular-specific (30.1%), infectious (28%), systemic non-infectious (16.5%) and idiopathic (23.6%). The highest percentage of uveitis with unspecified etiology (unclassified) was found in patients with intermediate uveitis and panuveitis (66.6% and 29.4% respectively). Infection was diagnosed in 54% of posterior uveitis cases and systemic immune-mediated disorders were commonly associated with panuveitis (55.8%).

In the 279 patients included in the retrospective review, the most frequent cause of uveitis was Fuchs uveitis (12.2%), toxoplasmosis (17.9%) and white dot syndromes (WDS) (10.4%). The WDS group of 29 patients included cases of multifocal choroiditis, punctate inner choroidopathy, acute posterior placoid pigment epitheliopathy, birdshot chorioretinopathy, subretinal fibrosis and uveitis, serpiginous choroiditis, multiple evanescent white dot syndrome, and acute annular outer retinopathy. Sarcoidosis (6.0%) and multiple sclerosis (4.7%) were the two systemic diseases most frequently identified in patients with uveitis at our center in Poland.

[Table 4](#t4-medscimonit-24-8734){ref-type="table"} summarizes the overall leading causes of uveitis, and the causes by gender. Apart from idiopathic inflammation, the most prevalent causes were toxoplasmosis (17.9%), Fuchs uveitis (12.2%), and WDS (10.4%). Significant differences between male and female patients were found for toxocariasis, toxoplasmosis and for HLA-B27-associated acute anterior uveitis (AAU).

Significant associations were found between the causes of uveitis and patient age for Fuchs uveitis, WDS, toxocariasis, and toxoplasmosis. In summary, the findings from the retrospective review of cases of uveitis from our department in Poland showed that an increase in the patient age by one year favored the occurrence of Fuchs uveitis and sarcoidosis, while a decrease in age by one year reduced the occurrence of WDS, toxocariasis, and toxoplasmosis ([Table 5](#t5-medscimonit-24-8734){ref-type="table"}). [Table 6](#t6-medscimonit-24-8734){ref-type="table"} shows the pattern of uveitis associated with the eye segments involved. The most common cause for anterior uveitis was Fuchs uveitis; the most common cause for intermediate and panuveitis was idiopathic inflammation; the most common cause for posterior uveitis was WDS.

Comparison of the retrospective observational study findings (Poland, 2005--2015) with the findings from the literature review of uveitis in Europe (1976--2017)
----------------------------------------------------------------------------------------------------------------------------------------------------------------

The results of the comparison of data between the retrospective study findings from our center in Poland between 2005--2015, and those from the literature review of findings in other European countries between 1976--2017 are shown in [Tables 7](#t7-medscimonit-24-8734){ref-type="table"}[](#t8-medscimonit-24-8734){ref-type="table"}[](#t9-medscimonit-24-8734){ref-type="table"}[](#t10-medscimonit-24-8734){ref-type="table"}[](#t11-medscimonit-24-8734){ref-type="table"}[](#t12-medscimonit-24-8734){ref-type="table"}[](#t13-medscimonit-24-8734){ref-type="table"}--[14](#t14-medscimonit-24-8734){ref-type="table"}. The literature review obtained data from 26 published studies (24,126 patients with uveitis) from 12 European countries, ranging from 120 cases in Finland in 1977, to 3,000 cases in the U.K. in 2015 \[[@b19-medscimonit-24-8734]--[@b43-medscimonit-24-8734]\]. The data were extracted from the 26 published studies and covered a period of 41 years, from 1976--2017. In eight out of the 26 studies the authors did not provide information about the nationality of the subjects. Another eight studies were carried out in ethnically uniform populations of a given country, and in nine studies the subjects came from multinational (multiethnic) populations. In 10 studies, the age range was not specified. Pediatric patients were included in 12 studies. The mean age of all reported patients was 40.4 years (range, 30.7--47.9 years). Women accounted for 52.3% of all patients (range, 42.5--61.6%). The published studies included in the literature review and the demographic characteristics of the study participants are summarized in [Tables 7](#t7-medscimonit-24-8734){ref-type="table"} and [8](#t8-medscimonit-24-8734){ref-type="table"}.

[Tables 9](#t9-medscimonit-24-8734){ref-type="table"}[](#t10-medscimonit-24-8734){ref-type="table"}[](#t11-medscimonit-24-8734){ref-type="table"}[](#t12-medscimonit-24-8734){ref-type="table"}[](#t13-medscimonit-24-8734){ref-type="table"}--[14](#t14-medscimonit-24-8734){ref-type="table"} summarize the etiology of uveitis in patients from selected studies published between 1976--2017. No obvious patterns could be observed, although non-infectious uveitis syndromes associated with systemic disease were the most prevalent in most European countries. Overall, the findings from the retrospective study performed at our center in Poland between 2005--2015 did not differ significantly from those in other European countries, but in our series of patients, ocular-specific syndromes were the most common (31.8% of all uveitis cases) and uveitis associated with systemic non-infectious disease were the least common (16.8%).

No consistent trends were observed regarding the anatomical localization of uveitis reported from the European studies between 1976--2017 ([Table 8](#t8-medscimonit-24-8734){ref-type="table"}), even when including and excluding our own department's observations from 2005--2015. During the 41 years covered by the literature review in Europe (1976--2017), the most common anatomical localization of uveitis reported was anterior, with the mean rate from all studies being 55.2%, ranging from 0.0% in Belgium (in 1999) to 92.2% in Finland (in 1994) \[[@b28-medscimonit-24-8734],[@b32-medscimonit-24-8734]\]. In our review from our department in Poland between 2005--2015, posterior uveitis was the most common location in 48.4% of cases, compared with the mean of 21.1% from the remaining European centers (from 1976--2017). Intermediate uveitis was the most common location in 12.9% of cases, compared with the mean of 9.0% from the remaining European centers (from 1976--2017). Panuveitis was the most common location in 12.2% of cases, compared with the mean of 14.9% from the remaining European centers (from 1976--2017).

Toxoplasmosis was diagnosed in 17.9% of all uveitis cases and was present in 35.5% of patients with posterior uveitis, whereas Fuchs uveitis was identified in 12.2% of all uveitis cases and was present in 45.9% of anterior uveitis cases. The WDS cases were associated with 10.4% of all cases, and with 21.5% of posterior uveitis cases. Uveitis from sarcoidosis was present in 6.1% of all cases, and in 11% of cases of intermediate uveitis, 2.9% of posterior uveitis, 2.7% of anterior uveitis, and 20.6% of panuveitis. Infection with *Toxocara* was related to 6.1% of all cases 11.8% of cases of posterior uveitis and 2.9% of cases of panuveitis. HLA B27 AAU was detected in 5.7% of all uveitis patients and 21.6% of patients with anterior uveitis. Multiple sclerosis was diagnosed in 4.7% of all patients and in 23.5% of panuveitis cases, 11.1% of intermediate uveitis cases, and 1.4% of anterior uveitis cases.

Regarding the etiology of uveitis, when the anatomical location was not considered ([Table 13](#t13-medscimonit-24-8734){ref-type="table"}), idiopathic uveitis was diagnosed in 36.3% of the patients in our series in Poland (2005--2015), without noticeable deviations from the pooled mean rate from other European centers. Fuchs uveitis was diagnosed in 6.1% of patients in studies from other European countries, which means that in our center, this rate was higher (12.2%). Ankylosing spondylitis was diagnosed in 8.2% of cases overall (3.6% in Poland between 2005--2015 compared with 8.7% in the other European centers between 1976--2017). Sarcoidosis was associated with 4.7% of cases of uveitis overall (6.5% in Poland between 2005--2015 compared with 4.7% in the other European centers between 1976--2017). Multiple sclerosis was diagnosed in 1.7% of cases overall (4.7% in Poland between 2005--2015 compared with 1.3% in the other European centers between 1976--2017). Toxoplasmosis was associated with 9.9% of uveitis cases overall (17.9% in Poland between 2005--2015 compared with 9.4% in the other European centers between 1976--2017) Toxocariasis was detected in 1.4% of all uveitis patients (6.0% in Poland between 2005--2015 compared with 0.5% in the other European centers between 1976--2017). Reiter's syndrome was diagnosed in 1.3% of uveitis patients overall (0.35% in Poland between 2005--2015 compared with 1.4% in the other European centers between 1976--2017). Tuberculosis was the underlying cause in 2.2% of all patients (0.7% in Poland between 2005--2015 compared with 2.3% in the other European centers between 1976--2017). Juvenile rheumatoid arthritis was diagnosed in 2.1% of all patients (0.4% in Poland between 2005--2015 compared with 2.4% in the other European centers between 1976--2017). WDS cases were present in 7.7% of all patients (10.4% in Poland between 2005--2015 compared with 7.2% in the other European centers between 1976--2017). Viral infections, mainly Herpes viruses, were found in 7.0% of all patients (2.5% in Poland between 2005--2015 compared with 7.2% in the other European centers between 1976--2017).

Discussion
==========

Although there have been several published epidemiological studies on uveitis conducted in Europe during the past few decades, there has been only one previously published study conducted in Poland, in 2001 \[[@b35-medscimonit-24-8734]\]. Therefore, the aim of this study was to review the causes, presentation, and clinicopathological associations of uveitis in our department of ophthalmology in Warsaw, Poland, between 2005--2015, and to compare the findings with previously published studies conducted in Europe between 1976--2017

In previously published European studies on uveitis, published between 1976--2017, more patients were included than in our series. This finding is likely due to the fact that in Warsaw there are two tertiary centers for referral of patients with uveitis, while mild cases of uveitis might be treated in private practice \[[@b48-medscimonit-24-8734]\]. The main difference in the results found between the present retrospective study and previously published European studies was found to be the most common anatomical localization of inflammation. In many European countries, anterior uveitis was found to be the most common form, accounting for 50--60% of all cases, while in study posterior uveitis was more prevalent \[[@b45-medscimonit-24-8734]--[@b47-medscimonit-24-8734]\]. The lower prevalence of anterior uveitis in our series may be explained by the fact that patients might have received treatment in smaller hospitals or private practice, and the increasingly frequent use of biologics in systemic autoimmune diseases has significantly reduced the occurrence of ocular complications.

The second main difference between the findings of our study, conducted in a single center in Poland between 2005--2015, compared with the previously published studies in Europe between 1976--2017, was our finding of a cause of uveitis in 77%. The literature review showed that during the past few decades, the rate of idiopathic uveitis has been decreasing, which is associated with advances in clinical diagnosis, including molecular diagnostic techniques \[[@b21-medscimonit-24-8734],[@b22-medscimonit-24-8734],[@b25-medscimonit-24-8734],[@b34-medscimonit-24-8734],[@b40-medscimonit-24-8734]\].

The main manifestations of uveitis observed from review at our center in Poland were ocular-specific (31.8%), infectious (27.9%) and associated with the underlying systemic non-infectious disease (16.8%), while 23.6% of all uveitis cases were unclassifiable. The prevalence of ocular- specific disease from our center in Poland was similar to that observed in Germany (34.3%) but was less than that diagnosed in France, Spain, and Austria \[[@b33-medscimonit-24-8734],[@b36-medscimonit-24-8734],[@b39-medscimonit-24-8734],[@b41-medscimonit-24-8734],[@b42-medscimonit-24-8734]\]. Infectious symptoms of uveitis observed from our center in Poland were found at a similar rate to those in France, but were reported less frequently in Germany, Austria, and Spain \[[@b33-medscimonit-24-8734],[@b36-medscimonit-24-8734],[@b39-medscimonit-24-8734],[@b41-medscimonit-24-8734],[@b42-medscimonit-24-8734]\]. The prevalence of systemic non-infectious disease from our center in Poland was the lower when compared with previously published studies from other European countries \[[@b33-medscimonit-24-8734],[@b36-medscimonit-24-8734],[@b39-medscimonit-24-8734],[@b40-medscimonit-24-8734]--[@b42-medscimonit-24-8734]\].

The main causes of uveitis in our department of ophthalmology in Warsaw, Poland, between 2005--2015 were Fuchs uveitis, toxoplasmosis, and the white dot syndrome (WDS), while in other European countries toxoplasmosis, ankylosing spondylitis, and HLA B-27 associated anterior uveitis (AAU) predominated \[[@b19-medscimonit-24-8734],[@b21-medscimonit-24-8734]--[@b23-medscimonit-24-8734],[@b25-medscimonit-24-8734],[@b27-medscimonit-24-8734],[@b32-medscimonit-24-8734],[@b34-medscimonit-24-8734],[@b40-medscimonit-24-8734]--[@b42-medscimonit-24-8734]\]. The prevalence of ocular toxoplasmosis in our series was similar to that in other European countries. Toxoplasmosis is a major cause of posterior uveitis, and the differences in the occurrence and clinical presentation depend on the time of infection (congenital versus acquired), the prevailing regional strains of the parasite, nutritional habits, host immune status, socio-economic conditions, and climate \[[@b45-medscimonit-24-8734]--[@b47-medscimonit-24-8734],[@b49-medscimonit-24-8734]--[@b57-medscimonit-24-8734]\].

In our series, toxocariasis as a cause of uveitis was reported to be higher, than in cases reported in previous European studies \[[@b58-medscimonit-24-8734]--[@b60-medscimonit-24-8734]\]. The seroprevalence of toxocariasis in Poland depends on the method of testing, the population groups, and the region, ranging from 5% in the Poznań region to 75.6% in Warsaw, which may explain such a high percentage of patients with ocular larva migrans (OLM) in patients with uveitis referred to our department \[[@b58-medscimonit-24-8734]--[@b60-medscimonit-24-8734]\]. Ocular larva migrans (OLM), or ocular toxocariasis, which is the ocular form of the larva migrans syndrome, is due to infection with *Toxocara canis*. For many years the number of pet dogs in Poland has been increasing. Based on the number of rabies vaccination certificates, it is now estimated at 7.5 million (one dog per five people) means that Poland has one of the largest dog populations in Europe \[[@b61-medscimonit-24-8734]\]. Dog feces in the street dry and particles may be inhaled into the bronchial tree and swallowed causing parasite infestation, a mechanism that may explain very high seroprevalence of toxocariasis in urban adults in Poland \[[@b62-medscimonit-24-8734]\].

Review of previously published studies has shown that tuberculosis is one of the most common causes of uveitis in Europe, predominantly in the Netherlands, UK, and Spain \[[@b21-medscimonit-24-8734]--[@b23-medscimonit-24-8734],[@b38-medscimonit-24-8734],[@b39-medscimonit-24-8734]\]. In our review of cases in our department in Poland, two cases of uveitis were found in patients with a history of tuberculous pneumonia. The incidence of tuberculosis in Poland decreased from 128.5 per 100,000 in 1970 to 19.1 per 100,000 in 2010 \[[@b63-medscimonit-24-8734],[@b64-medscimonit-24-8734]\]. The Polish tuberculosis control program has been developed continuously since the 1920s. In addition to mass vaccination with Bacillus Calmette-Guérin (BCG), there is a free but compulsory treatment of the disease, which also includes quite an aggressive family chemoprophylaxis \[[@b63-medscimonit-24-8734],[@b64-medscimonit-24-8734]\]. In many countries, with the improvement of tuberculosis control, the rate of extrapulmonary forms of tuberculosis is increasing, which has not been observed in Poland. Another explanation is that in Western Europe the increase in the incidence of tuberculosis may be associated with growing numbers of migrants, mainly from Africa and Asia, including countries where tuberculosis has appeared fairly recently and there are no vaccination programs in place, making people more susceptible to the infection. Currently, the population of Poland is ethnically uniform and the immigrants come mainly from Ukraine and other countries of the former USSR \[[@b39-medscimonit-24-8734],[@b63-medscimonit-24-8734],[@b64-medscimonit-24-8734]\].

Limited epidemiological data are available in Poland on the prevalence of systemic diseases which can be associated with uveitis \[[@b7-medscimonit-24-8734],[@b8-medscimonit-24-8734],[@b65-medscimonit-24-8734]--[@b67-medscimonit-24-8734]\]. Review of our local patient records between 2005--2015 in Warsaw, Poland, showed an association with systemic diseases in 16.8% of patients with uveitis patients, which was generally less than in previously published European studies \[[@b33-medscimonit-24-8734],[@b36-medscimonit-24-8734],[@b42-medscimonit-24-8734]\]. Most frequently, our cases of uveitis were associated with sarcoidosis (6.0%) and multiple sclerosis (4.7%) and seldom with some form of arthritis (0.4%). A similar prevalence of uveitis from sarcoidosis was observed in the patient populations from the Netherlands and Belgium, but not in Portugal, Italy, or Spain \[[@b22-medscimonit-24-8734],[@b25-medscimonit-24-8734]--[@b27-medscimonit-24-8734],[@b30-medscimonit-24-8734],[@b32-medscimonit-24-8734],[@b39-medscimonit-24-8734],[@b42-medscimonit-24-8734]\].

Uveitis can be the first symptom of multiple sclerosis (MS) \[[@b65-medscimonit-24-8734]--[@b68-medscimonit-24-8734]\]. In Poland, the prevalence of MS in the last 60 years has ranged from 37--91 per 100,000 depending on the region of the country \[[@b69-medscimonit-24-8734]\]. In our retrospective study, uveitis associated with MS was more common than in other European countries, including the Netherlands, France, Germany, the UK, Spain, and Austria \[[@b23-medscimonit-24-8734],[@b33-medscimonit-24-8734],[@b36-medscimonit-24-8734],[@b38-medscimonit-24-8734]--[@b41-medscimonit-24-8734]\].

This study had several limitations. A retrospective review of clinical data was conducted at a single center, which was dependent on the quality of the information recorded. A small number of patients was included in this observational study, although records covering a period of 10 years were collected. Also, other European studies included secondary data from multi-ethnic populations and patients under the age of 18 years who could not be statistically evaluated.

Conclusions
===========

The difficulties facing epidemiologists in studying the patterns of uveitis are well known and have previously been highlighted by Nashtanei et al., who recommended that classification systems for uveitis should be universally adopted and that population-based studies in all countries should be compared to provide more reliable epidemiological data \[[@b70-medscimonit-24-8734]\]. The findings of this retrospective observational study conducted in our department in Warsaw, Poland between 2005--2015 and comparison with a review of the published literature from other European countries between 1976--2017 support this view, even though the incidence of causes of uveitis in Poland was similar to those in the rest of Europe. It is possible that any differences in the Polish population arise from genetic, socio-economic, and health care, including vaccination programs for certain infections. There may also be differences between countries in the ability to recognize and diagnose uveitis, which results from differences in medical education, medical staff experience, the level of health care, and the availability of diagnostic investigations \[[@b45-medscimonit-24-8734]--[@b47-medscimonit-24-8734]\]. Because identifying the cause of uveitis is required for appropriate treatment, as we have shown, a multidisciplinary approach to the diagnosis and management of patients with uveitis requires collaboration between the ophthalmologist and a team of specialists in other areas of medicine.
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###### 

Final overall diagnosis by gender in the single center retrospective observational study from Poland (2005--2015).

  Diagnosis              Overall (n=279)                                                 Women (n=172)                                                   Men (n=107)   RRR [\*](#tfn1-medscimonit-24-8734){ref-type="table-fn"} (95% CI)   p-Value
  ---------------------- --------------------------------------------------------------- --------------------------------------------------------------- ------------- ------------------------------------------------------------------- ------------
  Anterior uveitis       74 (26.5)                                                       38 (22.1)                                                       36 (33.6)     1.79 (1.04--3.06)                                                   =0.035
  Intermediate uveitis   36 (12.9)                                                       19 (11.1)                                                       17 (15.9)     1.52 (0.75--3.08)                                                   =0.243
  Posterior uveitis      135 (48.4)                                                      88 (51.2)                                                       47 (43.9)     0.69 (0.43--1.12)                                                   =0.240
  Panuveitis             34 (12.2)                                                       27 (15.7)                                                       7 (6.5)       **0.38 (0.16--0.90)**                                               **=0.028**
  **p-value**            **=0.021**[b](#tfn3-medscimonit-24-8734){ref-type="table-fn"}   **=0.025**[a](#tfn2-medscimonit-24-8734){ref-type="table-fn"}                                                                                     

A multinomial logistic regression model was fitted, where the relative risk ratios (RRR) and the corresponding confidence intervals (CI) were computed for men versus women within each diagnostic category, versus all other categories;

-- a p-value for the joint model was provided.

-- the chi-squared test of independence was performed for comparison purposes.

###### 

Overall patient age (years) and age by gender in the single center retrospective observational study from Poland (2005--2015) (mean ±SD).

  Diagnosis              Overall     Women       Men         p-Value[\*](#tfn4-medscimonit-24-8734){ref-type="table-fn"}
  ---------------------- ----------- ----------- ----------- ----------------------------------------------------------------
  Anterior uveitis       44.0±16.2   47.1±16.8   40.6±15.1   
                                                             
  Intermediate uveitis   32.1±11.9   33.2±12.7   30.8±11.0   **\<0.001**[a](#tfn5-medscimonit-24-8734){ref-type="table-fn"}
                                                             
  Posterior uveitis      34.3±13.2   33.9±13.6   35.2±12.5   
                                                             
  Panuveitis             48.7±13.1   49.1±10.9   47.0±20.7   =0.261[b](#tfn6-medscimonit-24-8734){ref-type="table-fn"}
                                                             
                         38.3±15.3   39.1±15.3   37.1±15.4   

A factorial analysis of variance (ANOVA) was performed; dependent variables were:

-- diagnosis,

-- gender.

###### 

Distribution of final diagnoses by anatomical classification in the single center retrospective observational study from Poland (2005--2015) (number of patients, %).

                  Idiopathic   Toxoplasmosis   Fuchs uveitis   White dot syndromes   Toxocariasis   Sarcoidosis   HLA B-27 AAU   Multiple sclerosis   Ankylosing spondylitis   Viruses   RIS       Rheumatoid arthritis   IRVAN     Tuberculosis   Reiter syndrome   Juvenile idiopathic arthritis   Ulcerative Colitis   Hepatitis C   Boreliosis
  --------------- ------------ --------------- --------------- --------------------- -------------- ------------- -------------- -------------------- ------------------------ --------- --------- ---------------------- --------- -------------- ----------------- ------------------------------- -------------------- ------------- ------------
  Anterior        9 (12)       0               34 (45.9)       0                     0              2 (2.7)       16 (21.6)      1 (1.35)             8 (10.8)                 0         0         1 (1.35)               0         0              1 (1.35)          1 (1.35)                        1 (1.35)             0             0
  Intermediate    24 (66.6)    0               0               0                     0              4 (11)        0              4 (11)               0                        0         3 (8.3)   0                      0         0              0                 0                               0                    1             0
  Posterior       23 (16.6)    48 (35.5)       0               29 (21)               16 (11.8)      4 (2.96)      0              0                    0                        6 (4.3)   1 (0.7)   1 (0.74)               4 (2.9)   2 (0.7)        0                 0                               0                    0             1
  Panuveitis      10 (29.4)    2 (5.6)         0               0                     1 (2.8)        7 (20.6)      0              8 (23.5)             2 (5.6)                  1 (2.1)   1 (2.9)   2 (5.6)                0         0              0                 0                               0                    0             0
  Total No. (%)   66 (23.7)    50 (17.9)       34 (12.2)       29 (10.4)             17 (6.1)       17 (6.1)      16 (5.7)       13 (4.7)             10 (3,6)                 7 (2.5)   5 (1.8)   4 (1.4)                4 (1.4)   2 (1.5)        1 (0.36)          1 (0.36)                        1 (0.36)             1 (0.36)      1 (0.36)

HLA-B27 AAU -- HLA-B27 associated acute anterior uveitis (AAU) without systemic disease; RIS -- radiologically isolated syndrome, or demyelinating changes on magnetic resonance imaging (MRI) without clinical signs of multiple sclerosis \[[@b17-medscimonit-24-8734]\]; WDS -- white dot syndrome, a group of inflammatory disorders that affect the outer retinal layers, retinal pigment epithelium (RPE) and/or choroid \[[@b18-medscimonit-24-8734]\]; IRVAN -- idiopathic retinal vasculitis, aneurysms, and neuroretinitis.

###### 

The overall leading causes of uveitis and causes by gender in the single center retrospective observational study from Poland (2005--2015).

  Diagnosis                 Overall     Women       Men         Logistic regression estimates   p-Value[\*](#tfn8-medscimonit-24-8734){ref-type="table-fn"}   
  ------------------------- ----------- ----------- ----------- ------------------------------- ------------------------------------------------------------- -----------
  Idiopathic inflammation   66 (23.7)   42 (24.4)   24 (22.4)   0.89                            0.50--1.59                                                    0.704
  Fuchs uveitis             34 (12.2)   17 (9.9)    17 (15.9)   1.72                            0.84--3.54                                                    0.139
  Multiple sclerosis        13 (4.7)    10 (5.8)    3 (2.8)     0.47                            0.13--1.74                                                    0.257
  White dot syndrome        29 (10.4)   19 (11.1)   10 (9.4)    0.83                            0.37--1.86                                                    0.651
  Sarcoidosis               17 (6.1)    13 (7.6)    4 (3.7)     0.47                            0.15--1.50                                                    0.204
  Toxocariasis              17 (6.1)    6 (3.5)     11 (10.3)   **3.17**                        **1.14--8.84**                                                **0.028**
  Toxoplasmosis             50 (17.9)   39 (22.7)   11 (10.3)   **0.39**                        **0.19--0.80**                                                **0.010**
  Viral aetiology           8 (2.9)     3 (1.7)     5 (4.7)     2.76                            0.65--11.80                                                   0.170
  HLA-B27 AAU               16 (5.7)    6 (3.5)     10 (9.4)    **2.85**                        **1.01--8.09**                                                **0.049**
  Ankylosing spondylitis    10 (3.6)    5 (2.9)     5 (4.7)     1.64                            0.46--5.80                                                    0.445

Logistic regression models were fitted.

OR -- odds ratio; CI -- confidence interval; HLA-B27 AAU -- HLA-B27 associated with acute anterior uveitis (AAU) without systemic disease.

###### 

Leading causes of uveitis by patient age (years) in the single center retrospective observational study from Poland (2005--2015) (mean ±SD).

  Diagnosis                 Present     Absent      Logistic regression estimates   p-Value[\*](#tfn10-medscimonit-24-8734){ref-type="table-fn"}   
  ------------------------- ----------- ----------- ------------------------------- -------------------------------------------------------------- -------------
  Idiopathic inflammation   42.5±17.0   37.1±14.2   **1.02**                        **1.01--1.04**                                                 **0.011**
  Fuchs uveitis             45.1±14.3   37.4±14.9   **1.03**                        **1.01--1.06**                                                 **0.004**
  Multiple sclerosis        39.4±11.1   38.3±15.2   1.00                            0.98--1.03                                                     0.798
  White dot syndromes       32.5±11.2   39.0±15.3   **0.97**                        **0.94--0.99**                                                 **0.027**
  Sarcoidosis               47.6±13.0   37.7±15.0   **1.04**                        **1.01--1.06**                                                 **0.002**
  Toxocariasis              29.8±11.9   38.9±15.1   **0.95**                        **0.90--0.99**                                                 **0.024**
  Toxoplasmosis             30.9±10.2   40.0±15.4   **0.95**                        **0.92--0.97**                                                 **\<0.001**
  Viral infections          36.8±19.3   38.4±14.9   0.99                            0.93--1.06                                                     0.866
  HLA-B27 AAU               36.3±16.1   38.5±15.0   0.99                            0.95--1.03                                                     0.677
  Ankylosing spondylitis    37.8±12.2   38.4±15.1   1.00                            0.96--1.03                                                     0.933

Logistic regression models were fitted.

Odds ratios (ORs) and corresponding confidence intervals (Cis) refer to the odds in favour of selected causes being diagnosed. The ORs were controlled for gender.

###### 

Diseases (causes) most frequently associated with uveitis by anatomical localization in the single center retrospective observational study from Poland (2005--2015).

  Diagnosis                 Anterior uveitis   Intermediate uveitis   Posterior uveitis   Panuveitis   p-Value[\*](#tfn12-medscimonit-24-8734){ref-type="table-fn"}
  ------------------------- ------------------ ---------------------- ------------------- ------------ --------------------------------------------------------------
  Idiopathic inflammation   9 (12.2)           24 (66.7)              23 (17.0)           10 (29.4)    **\<0.001**
  Fuchs uveitis             34 (45.9)          0 (0.0)                0 (0.0)             0 (0.0)      
  Multiple sclerosis        1 (1.4)            4 (11.1)               0 (0.0)             8 (23.5)     
  White dot syndrome        0 (0.0)            0 (0.0)                29 (21.3)           0 (0.0)      
  Sarcoidosis               2 (2.7)            4 (11.1)               4 (2.9)             7 (20.6)     **=0.002**
  Toxocariasis              0 (0.0)            0 (0.0)                16 (11.8)           1 (2.8)      
  Toxoplasmosis             0 (0.0)            0 (0.0)                48 (35.3)           2 (5.6)      
  Viral infection           0 (0.0)            1 (2.8)                7 (5.2)             1 (2.8)      
  HLA-B27 AAU               16 (21.6)          0 (0.0)                0 (0.0)             0 (0.0)      
  Ankylosing spondylitis    7 (9.5)            0 (0.0)                0 (0.0)             3 (8.3)      

Some p-values are not provided due to the data separation, or excess of frequencies of zero.

###### 

Demographic of patients diagnosed with uveitis in published studies from Europe (1976--2017).

  Country           First author          Year of publication   Patient nationality   Gender (% of women)   Mean age (years)   Pediatric patients included   Number of subjects
  ----------------- --------------------- --------------------- --------------------- --------------------- ------------------ ----------------------------- --------------------
  UK                James                 1976                                                                                                               368
  Finland           Miettinen             1977                  Finnish                                                                                      120
  The Netherlands   Kijlstra              1987                  Dutch                                                                                        1309
  Portugal          Palmares              1990                  Multiethnic           54.8                  36.0                                             450
  The Netherlands   Rothova               1992                  Multiethnic           50.0                  42.0               Yes                           865
  The Netherlands   Baarsma               1992                                                                                                               767
  Italy             Latanza               1993                                                                                                               369
  The Netherlands   Smit                  1993                  Dutch                 52.0                                     No                            750
  Switzerland       Tran                  1994                  Swiss                 42.5                  43.0               Yes                           435
  UK                Thean                 1996                  Multiethnic           48.0                  39.2               Yes                           712
  Italy             Pivetti-Pezzi         1996                                        53.0                  30.7                                             1417
  Finland           Päivönsalo-Hietanen   1997                                        49.0                                                                   1122
  Belgium           Levecq                1999                                                              36.5                                             201
  France            Bodaghi               2001                  Multiethnic                                 37.1               No                            927
  Italy             Mercanti              2001                  Italian               48.0                  44.4               Yes                           655
  Poland            Biziorek              2001                  Polish                53.3                  40.4               Yes                           563
  Germany           Jakob                 2009                                        57.0                                     Yes                           1916
  Italy             Cimino                2010                  Multiethnic           54.8                  41.0               Yes                           1064
  UK                Jones                 2015                  Multiethnic           54.1                  45.0               Yes                           3000
  Spain             Llorenç               2015                  Multiethnic           54.0                  45.0               Yes                           1022
  Germany           Grajewski             2015                  Multiethnic           55.0                                     Yes                           474
  Austria           Barisani-Asenbauer    2015                                        52.0                  38.8               Yes                           2619
  Spain             Fanlo                 2017                  Multiethnic           50.0                  47.9               No                            500
  Poland            our observation       2018                  Polish                61.7                  38.3               No                            282

Empty boxes: data not available.

###### 

Classification of uveitis by anatomical localization in studies from Europe (1976--2017).

  Country           First author                                                  Year of publication   Anterior uveitis (%)   Intermediate uveitis (%)   Posterior uveitis (%)   Panuveitis (%)
  ----------------- ------------------------------------------------------------- --------------------- ---------------------- -------------------------- ----------------------- ----------------
  UK                James                                                         1976                  58.0                   0.0                        18.0                    24.0
  Finland           Miettinen                                                     1977                  87.5                   0.0                        8.3                     4.1
  The Netherlands   Kijlstra                                                      1987                                                                                            
  Portugal          Palmares                                                      1990                  60.0                   4.0                        24.0                    12.0
  The Netherlands   Rothova                                                       1992                  54.5                   9.0                        16.5                    20.0
  The Netherlands   Baarsma                                                       1992                  50.7                   11.3                       23.1                    14.8
  Italy             Latanza                                                       1993                  52.0                   15.2                       28.0                    24.0
  The Netherlands   Smit                                                          1993                  52.0                   9.0                        24.0                    15.0
  Switzerland       Tran                                                          1994                  62.0                   11.0                       20.0                    7.0
  Finland           Päivönsalo-Hietanen                                           1994                  92.2                   1.3                        5.7                     0.8
  UK                Thean                                                         1996                                                                                            
  Italy             Pivetti-Pezzi                                                 1996                  49.1                   12.4                       22.1                    16.4
  Belgium           Levecq                                                        1999                  0.0                    14.4                       49.1                    35.8
  France            Bodaghi                                                       2001                  28.5                   15.0                       21.5                    35.0
  Italy             Mercanti                                                      2001                  58.0                   2.9                        26.1                    12.9
  Poland            Biziorek                                                      2001                  44.6                   7.3                        33.0                    15.1
  Germany           Jakob                                                         2009                  45.4                   22.9                       13.5                    6.2
  Italy             Cimino                                                        2010                  51.2                   5.8                        23.4                    19.6
  UK                Jones                                                         2015                  46.0                   11.1                       21.8                    21.1
  Spain             Llorenç                                                       2015                  52.0                   9.0                        23.0                    15.0
  Germany           Grajewski                                                     2015                  53.0                   19.0                       21.0                    7.0
  Austria           Barisani-Asenbauer                                            2015                  59.9                   14.8                       18.3                    7.0
  Spain             Fanlo                                                         2017                  65.4                   1.8                        17.6                    15.2
  Poland            **Retrospective observational study in Poland, 2005--2015**   **2005--2015**        **26.5**               **12.9**                   **48.3**                **12.2**

Empty boxes: data not available.

###### 

Etiologic distribution of anterior uveitis from the single center retrospective observational study from Poland (2005--2015) and in other studies from Europe (1976--2017) (% of all uveitis cases reported).

  Author/Country/Year                                           Idiopathic   Fuchs uveitis   HLA-B27 AAU   Ankylosing spondylitis   Sarcoidosis                                                Reiter syndrome   Multiple Sclerosis   Juvenile Idiopathic Arthritis   Rheumatoid Arthritis   Ulcerative colitis                                         Viral infection   Tuberculosis
  ------------------------------------------------------------- ------------ --------------- ------------- ------------------------ ---------------------------------------------------------- ----------------- -------------------- ------------------------------- ---------------------- ---------------------------------------------------------- ----------------- --------------
  Miettinen et al./Finland/1977                                 86.7         0.0             0.0                                                                                                                                                                                                                                                        1.9               1.0
  Rothova et al./The Netherlands/1992                           33.0         11.3                          9.0                      5.0[\*](#tfn16-medscimonit-24-8734){ref-type="table-fn"}                                          2.0                                                                                                               5.1               1.3
  Smit et al./The Netherlands/1993                              42.0         20.0                          14.0                     2.0[\*](#tfn16-medscimonit-24-8734){ref-type="table-fn"}   1.0                                    3.0                                                                                                               1.0               
  Tran et al./Switzerland/1994                                               10.0                                                                                                              1.8                                                                                                                                                      15.0              
  Pivetti-Pezzi et al./Italy/1996                               59.9         17.0                                                                                                                                                                                                                                                                       18.9              6.3
  Thean et al./UK/1996                                                       17.2                                                                                                                                                                                                                                                                                         
  Bodaghi et al./France/2001                                    13.6         9.5                                                    6.8                                                                          0.4                  9.5                                                                                                               31.0              4.9
  Mercanti et al./Italy/2001                                    58.0         17.0                                                   0.0                                                                                               2.9                             2.3                                                                               11.2              6.3
  Biziorek et al./Poland/2001                                   67.3                                                                                                                                                                                                                                                                                                      
  Jakob et al./Germany/2009                                     25.0         15.0                                                                                                                                                                                                                                                                       8.0               
  Cimino et al./Italy/2010                                      20.0         45.0                                                                                                                                                                                                                                                                       19.0              
  Jones/UK/2015                                                              25.0                                                                                                                                                                                                            1.3                                                                          
  Llorenç et al./Spain/2015                                     36.0         3.0             10.0          10.0                     0.7                                                        0.9               0.1                  3.0                             0.7                                                                               20.0              1.0
  Grajewski et al./Germany/2015                                 44.0         7.0             19.0          0.0                      11.0                                                       0.0               0.4                  4.0                             0.0                    0.4                                                        12.0              0.0
  Barisani-Asenbauer et al./Austria/2015                                     4.5             30.5                                   2.1                                                                                               3.4                                                    1.0[\*](#tfn16-medscimonit-24-8734){ref-type="table-fn"}   11.4              
  Fanlo et al./Spain/2017                                       31.2         4.6             4.2           16.5                                                                                                                                                                                                                                                           
  **Retrospective observational study in Poland, 2005--2015**   **12.2**     **45.9**        **21.6**      **11.0**                 **2.7**                                                    **2.7**           **1.35**             **1.35**                        **1.35**               **1.35**                                                   **0.0**           **0.0**
  Mean prevalence in Europe (own data not included)             43.0         13.7            16.0          9.9                      4.0                                                        0.9               0.3                  4.0                             1.0                    0.85                                                       13.0              3.0
  Mean prevalence in Europe (own data included)                 40.0         15.7            17.0          10.0                     3.8                                                        1.3               0.6                  3.6                             1.0                    1.0                                                        12.0              2.6

HLA-B27 AAU -- HLA-B27 associated acute anterior uveitis (AAU) without systemic disease. Empty boxes: data not available.

Suspected diagnosis.

###### 

Etiologic distribution of intermediate uveitis from the single center retrospective observational study from Poland (2005--2015) and in published studies from Europe (1976--2017) (% of all uveitis cases reported).

  Author/Country/Year                                           Idiopathic   Multiple Sclerosis   Sarcoidosis                                                 RIS       Hepatitis C   Tuberculosis                                               Boreliosis
  ------------------------------------------------------------- ------------ -------------------- ----------------------------------------------------------- --------- ------------- ---------------------------------------------------------- ------------
  Palmares et al./Portugal/1990                                 100.0                                                                                                                                                                            
  Rothova et al./The Netherlands/1992                           84.0         5.0                  9.0[\*](#tfn17-medscimonit-24-8734){ref-type="table-fn"}                                                                                       
  Smit et al./The Netherlands/1993                              69.0                              16.0[\*](#tfn17-medscimonit-24-8734){ref-type="table-fn"}                           7.0[\*](#tfn17-medscimonit-24-8734){ref-type="table-fn"}   
  Tran et al./Switzerland/1994                                  34.0                                                                                                                  2.0                                                        2.0
  Bodaghi et al./France/2001                                    75.5         10.8                 2.9                                                                                 1.4                                                        2.9
  Mercanti et al./Italy/2001                                    36.8                              0.0                                                                                                                                            
  Llorenç et al./Spain/2015                                     38.0         7.0                  5.0                                                                                 6.0                                                        
  Grajewski et al./Germany/2015                                 69.0         9.0                  18.0                                                        0.0       0.0           0.0                                                        0.0
  Barisani-Asenbauer et al./Austria/2015                        75.0         4.9                  1.5                                                                                                                                            
  **Retrospective observational study in Poland, 2005--2015**   **66.6**     **11.0**             **11.0**                                                    **8.3**   **2.7**       **0.0**                                                    **0.0**
  Mean prevalence in Europe (own data not included)             64.6         7.0                  5.5                                                                                 3.1                                                        2.4
  Mean prevalence in Europe (own data included)                 64.8         7.8                  6.4                                                                                 2.3                                                        1.6

Suspected diagnosis.

RIS, radiologically isolated syndrome. Empty boxes: data not available.

###### 

Etiologic distribution of posterior uveitis in the single center retrospective observational study from Poland (2005--2015) and in published studies from Europe (1976--2017) (% of all uveitis cases reported).

  Author/Country/Year                                           Idiopathic   Toxoplasmosis   White dot syndrome   Toxocariasis   Viral infection   IRVAN   Sarcoidosis                                                Tuberculosis                                               Boreliosis   RIS       Rheumatoid arthritis
  ------------------------------------------------------------- ------------ --------------- -------------------- -------------- ----------------- ------- ---------------------------------------------------------- ---------------------------------------------------------- ------------ --------- ----------------------
  Miettinen et al./Finland/1977                                 50.0         40.0                                 0.0                                                                                                 10.0                                                                              
  Kijlstraet al./The Netherlands/1987                                                        1.6                                                                                                                                                                                                        
  Rothova et al./The Netherlands/1992                           25.0         49.0                                 0.7            5.6                       9.0[\*](#tfn19-medscimonit-24-8734){ref-type="table-fn"}   1.0[\*](#tfn19-medscimonit-24-8734){ref-type="table-fn"}                          
  Smit et al./The Netherlands/1993                              28.0         42.0            10.0                 2.0            4.0                                                                                                                                                                    
  Tran et al./Switzerland/1994                                  18.0         42.0            4.5                                 4.0                       13.0                                                                                                                                         
  Pivetti-Pezzi et al./Italy/1996                               21.1         60.2                                 0.0                                                                                                                                                                                   
  Levecq L et al./UK/1996                                       17.0         39.0                                 1.0            4.0                                                                                  0.0                                                                               
  Bodaghi et al./France/2001                                    16.5         39.0                                                                          1.5                                                        0.5                                                                               
  Mercanti et al./Italy/2001                                    21.0         60.2                                 3.2            2.9                       1.2                                                        7.0                                                                               
  Jakob et al./Germany/2009                                     29.0         25.0                                                                                                                                                                                                                       
  Jones/UK/2015                                                              6.9                                                                                                                                                                                                                        
  Llorenç et al./Spain/2015                                     7.0          24.0            30.0                                7.0                       2.0                                                        11.0                                                                              
  Grajewski et al./Germany/2015                                 6.0          34.0            37.0                 0.0            9.0                       2.0                                                        0.0                                                        1.0                    
  Barisani-Asenbauer et al./Austria/2015                        21.9         29.0                                 1.4                                      2.5                                                                                                                                          
  Fanlo et al./Spain/2017                                                                    25.0                                                                                                                                                                                                       
  **Retrospective observational study in Poland, 2005--2015**   **17.0**     **35.5**        **21.5**             **11.8**       **4.4**           **3**   **2.96**                                                   **1.5**                                                    **1.0**      **0.8**   **0.74**
  Mean prevalence in Europe (own data not included)             21.7         37.7            18.0                 0.9            4.0                       3.7                                                        4.0                                                        1.0                    
  Mean prevalence in Europe (own data included)                 21.3         37.5            18.5                 2.1            4.0                       3.7                                                        3.7                                                        1.0                    

Suspected diagnosis.

RIS -- radiologically isolated syndrome; IRVAN -- idiopathic retinal vasculitis, aneurysms, and neuroretinitis. Empty boxes: data not available.

###### 

Etiologic distribution of panuveitis in the single center retrospective observational study from Poland (2005--2015) and in published studies from Europe (1976--2017) (% of all uveitis cases reported).

  Author/Country/Year                                           Idiopathic   Multiple sclerosis   Sarcoidosis                                                 Ankylosisng spodylitis   Toxoplasmosis   Rheumatoid arthritis   Toxocariasis   Viral infection   RIS       Tuberculosis                                               Boreliosis
  ------------------------------------------------------------- ------------ -------------------- ----------------------------------------------------------- ------------------------ --------------- ---------------------- -------------- ----------------- --------- ---------------------------------------------------------- ------------
  Miettinen et al./Finland/1977                                 20.0                              0.0                                                                                  60.0                                                                                                                                         
  Palmares et al./Portugal/1990                                                                   20.0[\*](#tfn21-medscimonit-24-8734){ref-type="table-fn"}                                                                                                                                                                         
  Rothova et al./The Nederlands/1992                            27.0                              19.0[\*](#tfn21-medscimonit-24-8734){ref-type="table-fn"}                            8.0                                                   5.0                         2.0[\*](#tfn21-medscimonit-24-8734){ref-type="table-fn"}   
  Smit et al./The Netherlands/1993                              39.0                              20.0[\*](#tfn21-medscimonit-24-8734){ref-type="table-fn"}                                                                                                              9.0[\*](#tfn21-medscimonit-24-8734){ref-type="table-fn"}   
  Tran et al./Switzerland/1994                                  35.0                              19.0                                                                                 6.0                                    3.0            23.0                                                                                   
  Pivetti-Pezzi et al./Italy/1996                               32.0                              3.5                                                                                  15.3                                                                                                                                         
  Levecq L et al./UK/1996                                       33.3                              12.5                                                                                 13.9                                                                                                                                         
  Bodaghi et al./France/2001                                    37.7                              10.5                                                                                 9.9                                                   4.3                         6.8                                                        
  Mercanti et al./Italy/2001                                    33.0         0.0                  3.5                                                                                  15.5                                                                              6.0                                                        
  Jakob et al./Germany/2009                                     32.0                              11.0                                                                                                                                                                   8.0                                                        
  Llorenç et al./Spain/2015                                     7.0          0.8                  13.0                                                        1                        11.0                                   0.6            1.0                         6.0                                                        
  Grajewski et al./Germany/2015                                 48.0         0.0                  29.0                                                        0                        0.0             0.0                    0.0            0.0                         0.0                                                        3.0
  Barisani-Asenbauer et al./Austria/2015                        19.6                              7.1                                                                                  15.8                                                  4.3                                                                                    
  **Retrospective observational study in Poland, 2005--2015**   **29.4**     **23.5**             **20.6**                                                    **6**                    **5.9**         **5.9**                **2.9**        **2.9**           **2.9**   **0.0**                                                    **0.0**
  Mean prevalence in Europe (own data not included)             30.3         0.3                  11.0                                                        0.5                      15.5                                   1.2            6.2                         5.3                                                        3.0
  Mean prevalence in Europe (own data included)                 30.2         6.0                  11.8                                                        2.3                      16.1                                   1.6            5.8                         3.8                                                        1.5

Suspected diagnosis.

RIS -- radiologically isolated syndrome. Empty boxes: data not available.

###### 

Etiologic distribution of uveitis in the single center retrospective observational study from Poland (2005--2015) and in published studies from Europe (1976--2017 (% of all uveitis cases reported).

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Autor/ County/ Year                                           Idiopathic   Established Etiology   Toxoplasmosis   Fuchs uveitis   White Dot Syndrome   Toxocarosis   Sarcoidosis   HLA-B27\   Mulitiple Sclerosis   Ankylosing spondylitis   Viral infection   Acute Retinal Necrosis   RIS       Rheumatoid Arthritis   IRVAN     Tuberculosis   Boreliosis   Juvenile Idiopathic Arthritis   Ulcerative colitis   Hepatitis C   Reiter Syndrom
                                                                                                                                                                                     AAU                                                                                                                                                                                                                                            
  ------------------------------------------------------------- ------------ ---------------------- --------------- --------------- -------------------- ------------- ------------- ---------- --------------------- ------------------------ ----------------- ------------------------ --------- ---------------------- --------- -------------- ------------ ------------------------------- -------------------- ------------- ----------------
  James/UK/1976                                                                                     10                                                                 7             7                                                         7                                                                                                    10                                                                              7

  Kijlstraet al./The Netherlands/1987                           44           56                     7               5                                                  5             18                                                        2                                                                                     1.8                         0.5                                                                1.1

  Palmares/Portugal/1990                                        63           37                     9.1             2.2                                                1.6           6.2                              12.2                     8.8                                                                                   2.2                                                                                            

  Rothova et al./The Netheerlands/1992                          30           70                     10              6                                                  9             17         0.7                   12.1                     8                                                                                     1.4                         0.9                                                                

  Latanza/Italy/1993                                            62           38                     13.5            1.3                                                0.6                                                                     1.3                                                                                                                                                                                  0.3

  Smit/The Netherlands/1993                                     42           58                     10              10.4                                 0.47          7             6                                7.2                      0.5               1                                                                   3                           1.6                                                                0.5

  Tran/Switzerland/1994                                         28           72                     9               6.2                                  0.2           6.7           15.4                             15.4                     14                2.5                                                                                                                                                                1.1

  Päivönsalo-Hietanen/Finland/1994                                                                                                                                                                                    12.8                                                                                                                                                                                                          

  Pivetti-Pezzi/Italy/1996                                      28           72                     7               8               12                                 0.4           2                                                         7.9                                                                                   2                                                                                              

  Thean/UK/1996                                                 27           73                                     13.2                                                                                                                                                                                                                                                                                                            

  Päivönsalo-Hietanen/Finland/1997                                                                  3               2                                                  2                                                                       2                                                                                     0.5                                                                                            

  Levecq/Belgium/1999                                           30           70                     24.4            0.5             3.5                                7.5           6                                                         2                                                                                     0                                                                                              

  Bodaghi/France/2001                                           34           66                     11.8            2.7                                                4.4           4.9        1.7                                            11.2              1.5                                                                 4              0.4          2.7                                                                

  Mercanti/Italy/2001                                           44           56                     17.7            2.14                                               0.8           2.4                                                       11.8                                                 1.4                              7                           1.7                                                                

  Biziorek/Poland/2001                                          30           70                                                                                                                                                                                                                                                                                                                                                     

  Jakob/Germany/2009                                            35           65                     4.2             6.9             3.8                                4.5           7.1        3.1                   4.3                      6.1                                                                                   1              1.4          3.3                                                                

  Cimino/Italy/2010                                             26           74                     6.9             22.7                                               1.6           5.3                                                       9.2                                                                                   4.4                                                                                            

  Jones/UK/2015                                                                                     6.9             11.5                                 0.86          11.6          4.5        1                                              5                 2                                                                   3.7                         3.7                                                                

  Llorenç/Spain/2015                                            26           74                     7               1               7                    0.1           3             13         0.8                   5                        15                0.6                                0.3                    0.1       5                           5                                                                  0.9

  Grajewski/Germany/2015                                        41           59                     7.1             3.5             9.7                  0             11.3          10.1       1.8                   1.9                      8.6               2                                  0                                0              0.4          1.9                             0.2                                0

  Barisani-Asenbauer /Austria/2015                              39           61                     6.6             3.36                                 0.68          2.44          10.3       1                     5.4                      8.6                                                  1.6                              0.8            0.3          2.2                                                                

  Fanlo/Spain/2017                                              31           69                     7.8             3                                                  2             4.2        0.8                   10.8                     9.2                                                  0,4                              0.4            0.2                                                                             0.2

  **Retrospective observational study in Poland, 2005--2015**   **23**       **77**                 **17.9**        **12.2**        **10.4**             **6**         **6**         **5.7**    **4.7**               **3.6**                  **2.5**           **2.5**                  **1.8**   **1.4**                **1.4**   **0.7**        **0.4**      **0.4**                         **0.4**              **0.35**      **0.35**

  Mean prevalence in Europe (own data not included)             36.6         63.3                   9.4             6.1             7.2                  0.5           4.65          8.2        1.3                   8.7                      7.2               1.6                                0.7                    0.1       2.3            2.1          2.4                             0.2                                1.4

  Mean prevalence in Europe (own data included)                 36           64                     9.9             6.5             7.7                  1.4           4.7           8          1.7                   8.2                      7                 1.7                      1.8       0.8                    0.75      2.2            1.9          2.1                             0.3                  0.35          1.3
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

RIS -- radiologically isolated syndrome; IRVAN -- idiopathic retinal vasculitis, aneurysms, and neuroretinitis. Empty boxes: data not available.

###### 

Uveitis in the single center retrospective observational study from Poland (2005--2015) and in published studies from Europe (1976--2017.

  Country      First author                                                  Year of publication   Unclassifiable (%)   Systemic noninfectious (%)   Infectious (%)   Ocular specific (%)
  ------------ ------------------------------------------------------------- --------------------- -------------------- ---------------------------- ---------------- ---------------------
  France       Bodaghi                                                       2001                  34.0                 25.0                         30.0             10.0
  Germany      Jakob                                                         2009                  0.0                  43.7                         22.4             34.3
  Spain        Llorenç                                                       2015                  26.0                 25.0                         29.0             20.0
  Germany      Grajewski                                                     2015                  41.0                 20.0                         17.0             23.0
  Austria      Barisani-Asenbauer                                            2015                  39.4                 19.5                         19.0             19.2
  Spain        Fanlo                                                         2017                  31.2                 29.2                         20.0             15.0
  **Poland**   **Retrospective observational study in Poland, 2005--2015**   **2005--2015**        **23.6**             **16.8**                     **27.9**         **31.8**

Fuchs uveitis, idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN); radiologically isolated syndrome (RIS); HLA-B27 associated acute anterior uveitis (AAU) without systemic disease;and white dot syndrome (WDS) were included in ocular specific group.
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